1Erythropoietin (EPO), a glycoprotein produced by specialized peritubular fibroblasts in 2 the kidney, is the master regulator of erythropoiesis. EPO is secreted into the plasma in 3 response to tissue hypoxia and stimulates erythroid differentiation and maturation. 4Though the transcriptional regulation of EPO has been well studied, the molecular 5 determinants of EPO secretion remain unknown. Here, we generated a HEK293T 6 reporter cell line that provides a quantifiable and selectable readout of intracellular EPO 7 levels. Using this cell line, we performed a genome-scale CRISPR screen that identified 8 SURF4 as an important mediator of EPO secretion. Targeting SURF4 with multiple 9 independent sgRNAs resulted in intracellular accumulation and extracellular depletion 10 of EPO. Both of these phenotypes were rescued by expression of SURF4 cDNA. 11Additionally, consistent with a role for SURF4 as an ER cargo receptor of EPO, we found 12 that disruption of SURF4 resulted in accumulation of EPO in the ER compartment, and 13 that SURF4 and EPO physically interact. Furthermore, SURF4 disruption in Hep3B 14 cells also caused a defect in the secretion of endogenous EPO, ruling out an artifact of 15 heterologous overexpression. This work suggests that SURF4 functions as an ER cargo 16 receptor that mediates the efficient secretion of EPO. Our findings also suggest that 17 modulating SURF4 may be an effective treatment for disorders of erythropoeisis that 18 are driven by aberrant EPO levels. Finally, we show that SURF4 overexpression results 19 in increased secretion of EPO, suggesting a new strategy for more efficient production of 20 recombinant EPO. 21